These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31172376)

  • 1. Fabrication of Dissolvable Microneedle Patches Using an Innovative Laser-Cut Mould Design to Shortlist Potentially Transungual Delivery Systems: In Vitro Evaluation.
    Albarahmieh E; AbuAmmouneh L; Kaddoura Z; AbuHantash F; Alkhalidi BA; Al-Halhouli A
    AAPS PharmSciTech; 2019 Jun; 20(5):215. PubMed ID: 31172376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
    Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation.
    Thatai P; Sapra B
    Ther Deliv; 2018 Feb; 9(2):99-119. PubMed ID: 29325509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transungual Gel of Terbinafine Hydrochloride for the Management of Onychomycosis: Formulation, Optimization, and Evaluation.
    Thatai P; Sapra B
    AAPS PharmSciTech; 2017 Aug; 18(6):2316-2328. PubMed ID: 28116600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
    Patel MM; Vora ZM
    Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
    Khattab A; Shalaby S
    AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hot-melt extruded drug delivery systems for onychomycosis.
    Mididoddi PK; Repka MA
    Eur J Pharm Biopharm; 2007 Apr; 66(1):95-105. PubMed ID: 17045468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
    Pal P; Thakur RS; Ray S; Mazumder B
    Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
    Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
    J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
    Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
    Nair AB; Vaka SR; Murthy SN
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of terbinafine hydrochloride and urea with an in situ film-forming system for nail targeting treatment.
    Yang F; Yu X; Shao W; Guo P; Cao S; Wang M; Wang Y; Wu C; Xu Y
    Int J Pharm; 2020 Jul; 585():119497. PubMed ID: 32504773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic approach to the formulation of anti-onychomycotic nail patches.
    Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
    Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
    Elsherif NI; Shamma RN; Abdelbary G
    AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.
    Tanrıverdi ST; Özer Ö
    Eur J Pharm Sci; 2013 Mar; 48(4-5):628-36. PubMed ID: 23295582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.